AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
Urinary kidney injury molecule 1 (uKIM-1) serves as a reliable marker for the early diagnosis of acute kidney injury (AKI). The rapid and facile detection of changes in uKIM-1 is essential for early AKI diagnosis, ultimately improving the prognosis of patients. In this study, we developed a fully printed photonic crystal-integrated microarray with photonic crystal-enhanced fluorescence properties, which can detect uKIM-1 levels at the point-of-care. We confirmed its efficacy in the early diagnosis of AKI using clinical urine specimens. Direct quantitative detection of uKIM-1 was achieved within 10 min. The lowest limit of detection is 8.75 pg·mL−1 with an accuracy of 94.2%. The diagnostic efficacy was validated using 86 clinical urine samples, highlighting the high sensitivity and stability of the photonic crystal microarray. Consequently, a facile and reliable immunoassay was designed and prepared for the rapid quantitative detection of uKIM-1, which is crucial for the early identification and convenient detection of AKI in hospital or community settings. Rapid, convenient, cost-effective, and long-term monitoring of changes in uKIM-1 levels can assist clinicians in making timely adjustments to treatment regimens, preventing the transition from AKI to chronic kidney disease (CKD), improving the quality of life of patients with AKI, and reducing healthcare costs. It highlights the advantages of utilizing urine samples as a noninvasive and easily accessible medium for early detection and monitoring of kidney-related conditions.
Geng, J. W.; Qiu, Y. X.; Qin, Z.; Su, B. H. The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: A systematic review and Bayesian meta-analysis. J. Transl. Med. 2021, 19, 105.
Zhou, G. H.; Zhao, W. C.; Zhang, C. Y.; Gao, X. Y.; Cheng, Q. L.; Gao, F. P. Manganese carbonyl-loaded hollow mesoporous silica nanoparticles coated with neutrophil membranes for acute kidney injury therapy. ACS Appl. Nano Mater. 2022, 5, 4130–4145.
Vijayan, A. Tackling AKI: Prevention, timing of dialysis and follow-up. Nat. Rev. Nephrol. 2021, 17, 87–88.
Jana, S.; Mitra, P.; Roy, S. Proficient novel biomarkers guide early detection of acute kidney injury: A review. Diseases 2022, 11, 8.
Kister, T. S.; Schmidt, M.; Heuft, L.; Federbusch, M.; Haase, M.; Kaiser, T. Laboratory diagnostic of acute kidney injury and its progression: Risk of underdiagnosis in female and elderly patients. J. Clin. Med. 2023, 12, 1092.
Wu, L. J.; Li, Y. Q.; Zhang, X. Z.; Chen, X. H.; Li, D. Y.; Nie, S.; Li, X.; Bellou, A. Prediction differences and implications of acute kidney injury with and without urine output criteria in adult critically ill patients. Nephrol. Dial. Transplant. 2023, 38, 2368–2378.
Mizdrak, M.; Kumrić, M.; Kurir, T. T.; Božić, J. Emerging biomarkers for early detection of chronic kidney disease. J. Pers. Med. 2022, 12, 548.
Pasala, S.; Carmody, J. B. How to use… serum creatinine, cystatin C and GFR. Arch. Dis. Child. Educ. Pract. Ed. 2017, 102, 37–43.
Liu, K. Z.; Tian, G. H.; Ko, A. C. T.; Geissler, M.; Brassard, D.; Veres, T. Detection of renal biomarkers in chronic kidney disease using microfluidics: Progress, challenges and opportunities. Biomed. Microdevices 2020, 22, 29.
Sampaio de Souza Garms, D.; Cardoso Eid, K. Z.; Burdmann, E. A.; Marçal, L. J.; Antonângelo, L.; Dos Santos, A.; Ponce, D. The role of urinary biomarkers as diagnostic and prognostic predictors of acute kidney injury associated with vancomycin. Front. Pharmacol. 2021, 12, 705636.
Neuen, B. L.; Kennedy, S. Biomarkers and personalised medicine in paediatric kidney disease. Lancet Child Adolesc. Health 2023, 7, 369–371.
Fazel, M.; Sarveazad, A.; Mohamed Ali, K.; Yousefifard, M.; Hosseini, M. Accuracy of urine kidney injury molecule-1 in predicting acute kidney injury in children; a systematic review and meta-analysis. Arch. Acad. Emerg. Med. 2020, 8, e44.
Zou, C. C.; Wang, C. T.; Lu, L. Advances in the study of subclinical AKI biomarkers. Front. Physiol. 2022, 13, 960059.
Zheng, S. X.; Zhou, X. M.; Qin, Y.; Yu, X. M.; Chen, L. L.; Liu, X. B.; Wang, Y. G.; Gong, J. G.; Shen, S. J.; Huang, B. Establishment of a time-resolved immunoassay for acute kidney injury based on the detection of Kim-1. J. Clin. Lab. Anal. 2022, 36, e24603.
Kot, K.; Kupnicka, P.; Witulska, O.; Czepan, A.; Łanocha-Arendarczyk, N. A.; Łanocha, A. A.; Kosik-Bogacka, D. I. Potential biomarkers in diagnosis of renal acanthamoebiasis. Int. J. Mol. Sci. 2021, 22, 6583.
Yin, Z. G.; Liu, C. J.; Yi, Y. J.; Wu, H. P.; Fu, X. H.; Yan, Y. R. A label-free electrochemical immunosensor based on PdPtCu@BP bilayer nanosheets for point-of-care kidney injury molecule-1 testing. J. Electroanal. Chem. 2022, 917, 116420.
Wu, C.; Dougan, T. J.; Walt, D. R. High-throughput, high-multiplex digital protein detection with attomolar sensitivity. ACS Nano 2022, 16, 1025–1035.
Chi, J. M.; Wu, Y. B.; Qin, F. F.; Su, M.; Cheng, N.; Zhang, J. B.; Li, C. B.; Lian, Z. W.; Yang, X.; Cheng, L. J. et al. All-printed point-of-care immunosensing biochip for one drop blood diagnostics. Lab Chip 2022, 22, 3008–3014.
Chen, H. X.; Luo, Z. Q.; Lin, X.; Zhu, Y. J.; Zhao, Y. J. Sensors-integrated organ-on-a-chip for biomedical applications. Nano Res 2023, 16, 10072–10099.
Fenzl, C.; Hirsch, T.; Wolfbeis, O. S. Photonic crystals for chemical sensing and biosensing. Angew. Chem., Int. Ed. 2014, 53, 3318–3335.
Su, M.; Song, Y. L. Printable smart materials and devices: Strategies and applications. Chem. Rev. 2022, 122, 5144–5164.
Ostermann, M.; Bellomo, R.; Burdmann, E. A.; Doi, K.; Endre, Z. H.; Goldstein, S. L.; Kane-Gill, S. L.; Liu, K. D.; Prowle, J. R.; Shaw, A. D. et al. Controversies in acute kidney injury: Conclusions from a kidney disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2020, 98, 294–309
Kellum, J. A.; Norbert Lameire for the KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1). Crit. Care 2013, 17, 204.
de Boer, I. H.; Khunti, K.; Sadusky, T.; Tuttle, K. R.; Neumiller, J. J.; Rhee, C. M.; Rosas, S. E.; Rossing, P.; Bakris, G. Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022, 102, 974–989.
Chen, T. K.; Knicely, D. H.; Grams, M. E. Chronic kidney disease diagnosis and management: A review. Jama 2019, 322, 1294–1304.
Lian, Z. W.; Wu, T. Q.; Wang, H. D.; Chi, J. M.; Cheng, L. J.; Xie, D. X.; Pan, X. Y.; Hu, Y. M.; Tan, Z. Y.; Chen, S. S. et al. At-home COVID-19 rapid antigen test down to 0.03 pg·mL−1 of nucleocapsid protein. Small 2023, 19, 2301162.
Chi, J. M.; Su, M.; Xue, B. J.; Cheng, L. J.; Lian, Z. W.; Yun, Y.; Yang, X.; Wang, X.; Xie, H. F.; Wang, H. D. et al. Fast and sensitive detection of protein markers using an all-printing photonic crystal microarray via fingertip blood. ACS Sens 2023, 8, 1742–1749.
Westhoff, J. H.; Fichtner, A.; Waldherr, S.; Pagonas, N.; Seibert, F. S.; Babel, N.; Tönshoff, B.; Bauer, F.; Westhoff, T. H. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr. Nephrol. 2016, 31, 2353–2363.
Priyadarshini, G.; Rajappa, M. Predictive markers in chronic kidney disease. Clin. Chim. Acta 2022, 535, 180–186.
Liu, C.; Debnath, N.; Mosoyan, G.; Chauhan, K.; Vasquez-Rios, G.; Soudant, C.; Menez, S.; Parikh, C. R.; Coca, S. G. Systematic review and meta-analysis of plasma and urine biomarkers for CKD outcomes. J. Am. Soc. Nephrol. 2022, 33, 1657–1672.
京公网安备11010802044758号